Share on Pinterest New research suggests that stopping GLP-1 drugs before pregnancy is linked to complications like gestational diabetes and preeclampsia. Tatsiana Volkava/Getty Images A recent study ...

WASHINGTON -- GLP-1 receptor agonist use for weight loss early in pregnancy was associated with a lower likelihood that gestational weight gain would be below recommended levels, according to a ...

In a study led by researchers at Mass General Brigham, pregnant individuals who stopped taking popular weight loss GLP-1 medications before or early in their pregnancy tended to gain more weight and ...

This article was reviewed by Craig Primack, MD, FACP, FAAP, FOMA. If you’re pregnant or hoping to become pregnant, it’s natural to have questions about your medications. And if you’re taking Ozempic®, ...

Discontinuing GLP-1 RAs before or during early pregnancy is linked to increased gestational weight gain and pregnancy complications. GLP-1 RAs are not recommended during pregnancy due to potential ...

New research shows that women who halt GLP-1 medications near conception face greater gestational weight gain and elevated risks for preterm birth and pregnancy-related complications, raising urgent ...

This virtual workshop examined issues related to obesity before, during, and after pregnancy. The webinar featured individual invited speakers and presentations that build on previous topics covered ...

Offspring of mothers with higher gestational weight gain faced heightened odds for asthma, rhinitis and allergic ...

GLP-1 receptor agonists are contraindicated in pregnancy. In a cohort of women primarily with obesity, GLP-1 receptor agonist exposure prior to pregnancy or in early pregnancy was associated with ...